Kharwel Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 1404.38%
- Ebitda -10476.42%
- Net Worth 49.16%
- Total Assets 903.42%
About Kharwel Pharma
Kharwel Pharma Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2019 (Five years and two months 17 days old ). Its registered office is in Gautam Buddha Nagar, Uttar Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Parth Gupta, Sachin Jain, and Brajesh Kumar serve as directors at the Company.
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230UP2019PTC124336
- Company No.
124336
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2019
- Date of AGM
31 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Kharwel Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parth Gupta  | Director | 26-Oct-2020 | Current |
| Sachin Jain | Director | 10-Dec-2019 | Current |
| Brajesh Kumar | Director | 26-Oct-2020 | Current |
Financial Performance of Kharwel Pharma.
Kharwel Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1404.38% increase in profit. The company's net worth Soared by an impressive increase of 49.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kharwel Pharma?
Unlock access to Kharwel Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prabha Orthopedic Centre Private LimitedParth Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kharwel Pharma?
Unlock and access historical data on people associated with Kharwel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kharwel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kharwel Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
